in a randomized prospective study , 66 patients with serious bacterial infections -- mainly lower respiratory tract infections -- were treated with either imipenem plus cilastatin ( 32 patients ) or ciprofloxacin ( 34 patients ) ;
C0004623
bacterial
C0008809
ciprofloxacin